Evaluating SARS-CoV-2 Spike Protein Antibodies
Corresponding Organization : Tianjin haihe hospital
Other organizations : Tianjin First Center Hospital, Tianjin Medical University, Nankai University, Sichuan University, West China Hospital of Sichuan University, Academy of Medical Sciences, MRC Human Immunology Unit, University of Oxford, Institute of Hematology & Blood Diseases Hospital
Variable analysis
- Titers of plasma IgG and mucosal sIgA against the spike protein (S) of SARS-CoV-2 prototype strain and BA.1, BA.1.1, BA.2, BA.2.12.1, BA.2.75, and BA.4/5
- Coating concentration of S protein of SARS-CoV-2 prototype strain and Omicron sublineages
- Plasma dilutions
- Coating concentration of S protein of SARS-CoV-2 prototype strain and Omicron sublineages (50 ng)
- Plasma dilutions (1/400)
- Second antibodies (horseradish peroxidase conjugated goat anti-human Fc specific polyclonal IgG or goat rabbit anti-human α chain specific polyclonal IgA)
- No positive or negative controls were explicitly mentioned.
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!